Literature DB >> 17716991

Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation.

Seiji Habara1, Keigo Dote, Masaya Kato, Shota Sasaki, Kenji Goto, Hiroaki Takemoto, Daiji Hasegawa, Osamu Matsuda.   

Abstract

AIMS: There is little knowledge about the predictors of left atrial appendage (LAA) thrombi in non-valvular atrial fibrillation (NVAF). We investigated the ability of D-dimer to predict LAA thrombi. METHODS AND
RESULTS: In this study, 925 patients with NVAF were enrolled. At the time of transoesophageal echocardiography (TEE), D-dimer levels were measured simultaneously. Significant independent predictors of LAA thrombi were the presence of congestive heart failure [odds ratio (OR) 3.10, 95% confidence interval (CI) 1.77-5.50, P < 0.0001), a history of recent embolic events (OR 3.39, 95% CI 1.90-6.04, P < 0.0001), and D-dimer levels (OR 97.6, 95% CI 17.3-595.8, P < 0.0001). Receiver operating characteristic analysis yielded an optimal cutoff value of 1.15 microg/mL for D-dimer to detect LAA thrombi. LAA thrombi were detected in 21.8% of patients with higher D-dimer values, whereas it was detected in only 3.1% of patients with lower D-dimer values. D-dimer cutoff level of 1.15 microg/mL had a negative predictive value of 97% for identifying LAA thrombi.
CONCLUSION: In patients with NVAF, D-dimer may be helpful for predicting the absence of LAA thrombi. D-dimer level was clinically useful to guide the management of patients with NVAF, especially for those complicated with congestive heart failure and/or recent embolic events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716991     DOI: 10.1093/eurheartj/ehm356

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  29 in total

1.  Association, mutual stabilization, and transcriptional activity of the STRA13 and MSP58 proteins.

Authors:  A V Ivanova; S V Ivanov; M L Lerman
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

2.  Mean corpuscular volume and red cell distribution width as predictors of left atrial stasis in patients with non-valvular atrial fibrillation.

Authors:  Rui Providência; Maria João Ferreira; Lino Gonçalves; Ana Faustino; Luís Paiva; Andreia Fernandes; Sérgio Barra; Joana Pimenta; António M Leitão-Marques
Journal:  Am J Cardiovasc Dis       Date:  2013-06-10

3.  Left atrial thrombi and spontaneous echo contrast in patients with atrial fibrillation : Systematic analysis of a single-center experience.

Authors:  A G Bejinariu; D U Härtel; J Brockmeier; R Oeckinghaus; A Herzer; U Tebbe
Journal:  Herz       Date:  2016-04-21       Impact factor: 1.443

4.  Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.

Authors:  Xiao Feng Hu; Rui Zhan; Shanhu Xu; Junjun Wang; Jiong Wu; Xiaoli Liu; Yaguo Li; Linhui Chen
Journal:  Clin Cardiol       Date:  2018-01-24       Impact factor: 2.882

5.  Atrial fibrillation, elevated troponin, ischemic stroke and adverse outcomes: understanding the connection.

Authors:  Rui Providência; Sérgio Barra; Luís Paiva
Journal:  Clin Res Cardiol       Date:  2013-06-24       Impact factor: 5.460

6.  Clinical features of patients with left atrial thrombus undergoing anticoagulant therapy.

Authors:  Shinya Sugiura; Eitaro Fujii; Michiharu Senga; Emiyo Sugiura; Mashio Nakamura; Masaaki Ito
Journal:  J Interv Card Electrophysiol       Date:  2011-12-23       Impact factor: 1.900

7.  D-Dimer assay as a non invasive test for the diagnosis of left atrial Thrombi in Indian patients with Rheumatic MS.

Authors:  M Rajappa; T N Sunil Roy; A Raj; V Trehan; V Mallika
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

8.  Body mass index and risk of left atrial thrombus in patients with atrial fibrillation.

Authors:  Ri-Bo Tang; Xiao-Hui Liu; Jérôme Kalifa; Zhi-An Li; Jian-Zeng Dong; Ya Yang; Xing-Peng Liu; De-Yong Long; Rong-Hui Yu; Chang-Sheng Ma
Journal:  Am J Cardiol       Date:  2009-12-15       Impact factor: 2.778

9.  Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.

Authors:  Boris Leithäuser; Jai-Wun Park
Journal:  Korean Circ J       Date:  2009-11-30       Impact factor: 3.243

10.  Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists.

Authors:  Gregory Y H Lip; Lars H Rasmussen; S Bertil Olsson; Eva C Jensen; Anders L Persson; Ulf Eriksson; Karin F C Wåhlander
Journal:  Eur Heart J       Date:  2009-08-18       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.